DK1937245T3 - Sammensætning til forebyggelse og behandling af venstre-ventrikulær hypertrofi hos dialysepatienter - Google Patents

Sammensætning til forebyggelse og behandling af venstre-ventrikulær hypertrofi hos dialysepatienter

Info

Publication number
DK1937245T3
DK1937245T3 DK06807318.8T DK06807318T DK1937245T3 DK 1937245 T3 DK1937245 T3 DK 1937245T3 DK 06807318 T DK06807318 T DK 06807318T DK 1937245 T3 DK1937245 T3 DK 1937245T3
Authority
DK
Denmark
Prior art keywords
prevention
treatment
left ventricular
composition
ventricular hypertrophy
Prior art date
Application number
DK06807318.8T
Other languages
English (en)
Inventor
Paolo Carminati
Marco Corsi
Original Assignee
Sigma Tau Ind Farmaceuti
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sigma Tau Ind Farmaceuti filed Critical Sigma Tau Ind Farmaceuti
Application granted granted Critical
Publication of DK1937245T3 publication Critical patent/DK1937245T3/da

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/205—Amine addition salts of organic acids; Inner quaternary ammonium salts, e.g. betaine, carnitine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/21—Esters, e.g. nitroglycerine, selenocyanates
    • A61K31/215—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids
    • A61K31/22—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids of acyclic acids, e.g. pravastatin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/66—Phosphorus compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/7024—Esters of saccharides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Emergency Medicine (AREA)
  • Molecular Biology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Cardiology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Organic Chemistry (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Medicines Containing Plant Substances (AREA)
  • Finger-Pressure Massage (AREA)
  • Professional, Industrial, Or Sporting Protective Garments (AREA)
  • Road Signs Or Road Markings (AREA)
DK06807318.8T 2005-10-17 2006-10-16 Sammensætning til forebyggelse og behandling af venstre-ventrikulær hypertrofi hos dialysepatienter DK1937245T3 (da)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US11/250,634 US20070087975A1 (en) 2005-10-17 2005-10-17 Compound useful for the prevention and treatment of left ventricular hypertrophy in dialysed patients
PCT/EP2006/067465 WO2007045639A1 (en) 2005-10-17 2006-10-16 Compound useful for the prevention and treatment of left ventricular hypertrophy in dialysed patients

Publications (1)

Publication Number Publication Date
DK1937245T3 true DK1937245T3 (da) 2011-08-08

Family

ID=37661169

Family Applications (1)

Application Number Title Priority Date Filing Date
DK06807318.8T DK1937245T3 (da) 2005-10-17 2006-10-16 Sammensætning til forebyggelse og behandling af venstre-ventrikulær hypertrofi hos dialysepatienter

Country Status (12)

Country Link
US (2) US20070087975A1 (da)
EP (1) EP1937245B1 (da)
JP (1) JP5106403B2 (da)
AT (1) ATE506946T1 (da)
CY (1) CY1112144T1 (da)
DE (1) DE602006021594D1 (da)
DK (1) DK1937245T3 (da)
ES (1) ES2364189T3 (da)
PL (1) PL1937245T3 (da)
PT (1) PT1937245E (da)
SI (1) SI1937245T1 (da)
WO (1) WO2007045639A1 (da)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN101209975B (zh) * 2006-12-29 2010-12-01 沈阳科硕营养科技有限公司 左旋肉碱富马酸钙及其制备方法与用途
EP2353596A1 (en) 2010-02-02 2011-08-10 SIGMA-TAU Industrie Farmaceutiche Riunite S.p.A. Combination composition, comprising as active ingredients L-carnitine or propionyl L-carnitine, for the prevention or treatment of chronic venous insufficiency

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IT1156741B (it) * 1978-05-15 1987-02-04 Sigma Tau Ind Farmaceuti Applicazione terapeutica della carnitina e di alcuni derivati acilati della carnitina nell'emodialisi
IT1156852B (it) * 1978-07-10 1987-02-04 Sigma Tau Ind Farmaceuti Procedimento industriale per la preparazione del d'canforato della l carnitinammide e del d canforato della d carnitinammide e sue applicazioni
US4434816A (en) * 1978-10-30 1984-03-06 Giovanni Bernard A Di Service line interior by-pass fitting
US4968719A (en) * 1989-04-03 1990-11-06 Sigma Tau, Industrie Farmaceutiche Riunite Spa Method for treating vascular disease
IT1277147B1 (it) * 1995-01-20 1997-11-04 Sigma Tau Ind Farmaceuti Uso della carnitina e i suoi derivati per ridurre gli effetti tossici della ciclosporina-a e di altri farmaci immunosoppressivi.
IT1290801B1 (it) * 1996-07-05 1998-12-11 Mendes Srl Uso della acetil l-carnitina, della isovaleril l-carnitina, della propionil l-carnitina o dei loro sali farmacologicamente accettabili
IT1294227B1 (it) * 1997-08-01 1999-03-24 Sigma Tau Ind Farmaceuti Composizione farmaceutica contenente l-carnitina o una alcanoil l-carnitina e alcoli alifatici a lunga catena utile per la prevenzione
AU1073400A (en) * 1999-10-11 2001-04-23 Sigma-Tau Industrie Farmaceutiche Riunite S.P.A. Use of l-carnitine and its alkanoyl derivatives as osmotic agents in solutions for medical use
FR2846886A1 (fr) * 2002-11-08 2004-05-14 Merck Sante Sas Utilisation de fosinopril pour diminuer les evenements cardiovasculaires chez des patients dialyses

Also Published As

Publication number Publication date
JP5106403B2 (ja) 2012-12-26
CY1112144T1 (el) 2015-11-04
DE602006021594D1 (de) 2011-06-09
US20070087975A1 (en) 2007-04-19
PT1937245E (pt) 2011-07-06
US20080234373A1 (en) 2008-09-25
ATE506946T1 (de) 2011-05-15
EP1937245A1 (en) 2008-07-02
PL1937245T3 (pl) 2011-09-30
WO2007045639A8 (en) 2007-06-14
SI1937245T1 (sl) 2011-11-30
WO2007045639A1 (en) 2007-04-26
EP1937245B1 (en) 2011-04-27
ES2364189T3 (es) 2011-08-26
JP2009511619A (ja) 2009-03-19

Similar Documents

Publication Publication Date Title
NO20085338L (no) Substituerte 1,3-difenylpropanderivater, sammensetninger og anvendelser derav
EA200802184A1 (ru) Фармацевтические композиции с ингибиторами dpp iv
BRPI0815577A2 (pt) Peptídeo foxm1 e agente medicinal compreendendo o mesmo.
NO343776B1 (no) Forbindelse som modulerer farmakokinetikkegenskaper til terapeutika, dens anvendelse i terapi og farmasøytisk sammensetning derav.
BRPI0911203A2 (pt) peptídeo ou derivado de peptídeo, composição farmacêutica, uso de um peptídeo ou derivado de peptídeo, métodos para tratar um paciente tendo uma deficiencia e para preparar o peptídeo ou derivado de peptídeo.
WO2007038459A3 (en) Carboxyamine compounds and their use in the treatment of hdac dependent diseases
ATE456369T1 (de) Flibanserin zur behandlung von harninkontinenz und assoziierten erkrankungen
WO2007149406A8 (en) Modified coagulation factor ix polypeptides and use thereof for treatment
MXPA05008406A (es) Compuestos de amida tri(ciclo)-sustituida.
EA201200550A1 (ru) Фармацевтические композиции, включающие bi-1356 и метформин
MY148723A (en) Use of pinolenic acid for the treatment of obesity
DK1594833T3 (da) 1-phenylalkancarboxylsyrederivater til behandling af neurodegenerative sygdomme
CY1110182T1 (el) Ιδεβενονη για τη θεραπεια των μυϊκων δυστροφιων
UA91848C2 (ru) Применение соединений диосметина в лечении и предотвращении тромботическим патологиям
DK1220670T3 (da) Anvendelse af L-carnitin og dets alkanoylderivater som osmotiske stoffer i oplösninger til medicinsk anvendelse
DK1771155T3 (da) Fremgangsmåde og sammensætning til behandling af rhinitis
DE60318327D1 (de) Verwendung von resveratrol zur herstellung eines arzneimittels zur behandlung von grippe
DK2193789T3 (da) Anvendelse af 3,5-dihydroxytoluen eller derivater deraf i fremstillingen af medicin og funktionelle fødevarer til behandling eller forebyggelse af depression
DE602006002608D1 (de) 4-phenyl-5-oxo-l,4,5,6,7,8-hexahydrochinolin-derivate als arzneimittel zur behandlung von unfruchtbarkeit
ATE506946T1 (de) Verbindung zur prävention und behandlung von linksventrikulärer hypertrophie bei dialyse- patienten
DK1869185T3 (da) Konjugat med P21-protein til kræftbehandling
WO2006123164A3 (en) Lps-binding and bactericidal cytokines and interferons
ATE550019T1 (de) Cis-4-ä(4-chlorophenyl)sulfonylü-4-(2,5- difluorophenyl)cyclohexanepropansäure zur behandlug von krebs
CY1110576T1 (el) Χρηση της ακετυλ l-καρνιτινης για τη θεραπεια του ινομυαλγικου συνδρομου
DK1490049T3 (da) Citalopram til behandling af forhöjet blodtryk